|premium|

TLRY Stock Price and Forecast: Tilray Inc downgraded by Piper Sandler but raises price target to $26

  • TLRY downgraded by Piper Sandler but raises price target to $26.
  • Tilray is the focus of retail investor interest pushing cannabis stocks.
  • TLRY is a Canadian cannabis producer, shares up 300% in 2021!

Update February 18: Shares in Tilray brushed off a downgrade from Piper sandler on Thursday and remain strong. TLRY shares are trading at $33.61 in Thursday's pre-market, a gain of 6%. Piper Sandler raised the price target from $15 to $26 but downgraded it's rating to neutral.

TLRY has latched onto the pot boom for 2021 as retail traders look to jump on the next big thing.

Cannabis shares have been the hot trend of 2021 as investors look for the US market to open up and follow the Canadian liberalization of cannabis markets. Canada opened up its cannabis market in 2018. The new US administration, under President Biden, is seen as more amenable to opening up the cannabis market, compared to the previous administration.

Coupled with this has been the flood of new retail entrants to the trading arena. With time to spare and in some cases stimulus cash to invest, they have been wielding considerable influence on the stock market so far in 2021.

Tilray is a Canadian cannabis grower and as a result, the bulk of its sales are in Canada. But it has some other strings to its bow. Tilray has production facilities in Europe to try and tap into that growing market. Tilray also has a partnership with AB InBev to produce cannabis-infused drinks.

TLRY Stock news

Tilray shares have been on a rollercoaster ride, shooting up to $76 on Wednesday before collapsing back to $31 at the time of writing.

The rise-and-fall has largely been attributed to the Reddit phenomenon, with TLRY and other cannabis stocks trending on the retail websites and the interest skyrocketing. Some cannabis stocks also were significantly shorted which led to the rally. 

On Thursday many market commentators and analysts downgraded their views on cannabis stocks which saw sharp declines across the sector.

GLJ analyst Gordon Johnson reiterated his sell rating on Tilray (TLRY) with a $0 price target.

Should I Buy TLRY now?

Well, the answer with all these speculative shares is to be prepared for losses and only invest what you can afford to lose.

TLRY is a highly speculative play and as can be seen from its price action, discretion and risk management is required. 

Tilray

The author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.

This article is for information purposes only. The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice. It is important to perform your own research before making any investment and take independent advice from a registered investment advisor. 

FXStreet and the author do not provide personalized recommendations. The author makes no representations as to accuracy, completeness, or the suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. The author will not be held responsible for information that is found at the end of links posted on this page. 

Premium

You have reached your limit of 3 free articles for this month.

Start your subscription and get access to all our original articles.

Subscribe to PremiumSign In

Author

Ivan Brian

Ivan Brian

FXStreet

Ivan Brian started his career with AIB Bank in corporate finance and then worked for seven years at Baxter. He started as a macro analyst before becoming Head of Research and then CFO.

More from Ivan Brian
Share:

Editor's Picks

GBP/USD fails to reclaim 1.3200 as focus shifts to US data

GBP/USD loses its traction and declines toward 1.3150 following a short-lasting recovery attempt to the 1.3200 region in the early European session. The potential upside for the pair appear limited amid UK political instability and rising expectations of US interest rate hikes this year. Traders await the US May PCE inflation data on Thursday for a clear direction.

EUR/USD drops below 1.1350 ahead of US PCE inflation

EUR/USD struggles to stage a rebound and trades in negative territory below 1.1350 on Thursday. The cautious market stance helps the US Dollar holds its ground and weighs on the pair as market focus shifts to US PCE inflation report for May.

Gold struggles to stabilize above $4,000

Gold stays on the back foot after suffering heavy losses on Wednesday and trades below $4,000 on Thursday. The commodity sticks to its bearish bias for the third straight day, and remains close to the lowest level since November 2025, touched on Wednesday, as traders await the crucial US inflation data.

Bitcoin tests $60,000 as whales sell off – Aave and Jupiter show resilience

The broader cryptocurrency market remains under intense selling pressure, with Bitcoin back at $60,000 for the third time this year. On-chain data shows selling pressure from large-wallet investors, commonly referred to as whales, while total liquidations hit nearly $1 billion in 24 hours.

Bitcoin nears make-or-break level ahead of US PCE data

Bitcoin recovers slightly, trading at $61,700 after reaching a new yearly low of $59,103 and a 21-month low the previous day. This bearish price action is supported by the ongoing institutional sell-off, which recorded an outflow of over $469 million on Wednesday.

Regime change: Inside Kevin Warsh's first move to make the Fed unreadable on purpose

The rate did not move. That was the least interesting thing about Kevin Warsh's first meeting in charge of the Fed. The FOMC held its benchmark at 3.50%-3.75% for the fourth straight meeting, exactly as priced, and then the new chair used his first press conference to dismantle the machinery the market has leaned on for a decade.